期刊文献+

尿白蛋白肌酐比与2型糖尿病患者颈动脉内膜中层厚度的相关性研究 被引量:2

原文传递
导出
摘要 目的探讨尿白蛋白肌酐比(UACR)与2型糖尿病患者颈动脉内膜中层厚度(cIMT)的关系和临床意义。方法采用横断面试验设计,纳入316例2型糖尿病患者,留取晨尿标本测定UACR,cIMT采用彩色多普勒超声显像仪进行测量。依据UACR水平将所有患者分为正常白蛋白尿者220例、微量白蛋白尿者64例和大量白蛋白尿者32例。组间比较采用方差分析或卡方检验。采用Pearson相关分析或Spearman相关分析评价cIMT与临床指标的关系,采用多元逐步回归分析确定cIMT的独立影响因素。结果大量白蛋白尿组cIMT〔(0.94±0.25)mm〕高于正常白蛋白尿组〔(0.78±0.17)mm〕(P<0.05),微量白蛋白尿组的cIMT〔(0.89±0.18)mm〕高于正常白蛋白尿组(P<0.05);cIMT与年龄、糖尿病病程、收缩压、UACR呈正相关(P<0.05),与估算肾小球滤过率(eGFR)呈负相关(P<0.05);糖尿病病程和UACR是cIMT的独立影响因素(P<0.01)。结论 UACR是2型糖尿病患者cIMT的独立危险因素,增加动脉粥样硬化的发生风险,应进行早期防治。
出处 《四川大学学报(医学版)》 CAS CSCD 北大核心 2013年第3期485-488,共4页 Journal of Sichuan University(Medical Sciences)
  • 相关文献

参考文献15

  • 1Waehtell K, Ibsen H, Olsen H, et al. Albuminuria and cardiovascular risk in hypertensive patients with left ventricular hypertrophy: the LIFE Study. Ann Intern Med, 2003, 139 (11) :901-906.
  • 2Gerstein H, Mann JF, Yi Q, et al. Albuminuria and risk of cardiovascular events, death and heart failure in diabetic and nondiabetic individuals. JAMA,2001 ,286(4) :421-426.
  • 3Romundstad S,Holmen J,Kvenild K, et al. Microalbuminuria and all-cause mortality in 2,089 apparently healthy individuals: a 4.4-year follow-up study. The Nord-Trondelag Health Study (HUNT), Norway. Am J Kidney Dis,2003,42(3) :466-473.
  • 4Stehouwer CD,Gall MA,Twisk JW, et al. Increased urinary albumin excretion, endothelial dysfunction, and chronic low- grade in ammation in type 2 diabetes. Progressive, interrelated, and independently associated with risk of death. Diabetes, 2002 ,51 (4) :1157-1165.
  • 5何冰,韩萍,吕先科.2型糖尿病患者急性时相蛋白与糖尿病肾病的关系[J].中华内分泌代谢杂志,2003,19(4):260-262. 被引量:170
  • 6Levey AS, Cattran D, Friedman A, et al. Proteinuria as a surrogate outcome in CKD: report of a scientific workshop sponsored by the National Kidney Foundation and the US Food and Drug Administration. Am J Kidney Dis, 2009 , 54 (2) : 205- 226.
  • 7张锦标,陈远洗,祝年丰.台湾地区学生单次尿液之尿蛋白/尿肌酐比值与24小时尿液尿蛋白质排泄量之研究.中华医学杂志(台湾),2000;63(11):828-832.
  • 8Kawamoto R, Ohtsuka N, Kusunoki T,et al. An association between the estimated glomerular filtration rate and carotid atheroselerosis. Intern Med,2008,47(5) :391-398.
  • 9Yokoyama H, Aoki T, Imahori M, et al. Subclinical atherosclerosis is increased in type 2 diabetic patients with microalbuminuria evaluated by intima-media thickness and pulse wave velocity. Kidney Int, 2004 ; 66(1) : 448-454.
  • 10Furtner M, Kiechl S, Mair A, et al. Urinary albumin excretion is independently associated with carotid and femoral artery atherosclerosis in the general population. Eur Heart J, 2005;26(3) :279-287.

二级参考文献7

  • 1Cabay C, Kushner I. Acute-phase proteins and other systemic responses to inflammation. N Engl J Med, 1999,340:448-454.
  • 2Donald E. Increased levels of acute-phase serum proteins in diabetes. Metabolism, 1989,38:1042-1046.
  • 3Pickup JC, Crook MA. Is type 2 diabetes mellitus a disease of the innate immune system. Diabetologia, 1998,41:1241-1248.
  • 4Martin A, Crook P, John C, et al. Relationship between plasma sialic acid concentration and microvascular and macrovascular complications in type 1 diabetes. Diabetes Care, 2001,24:316-321.
  • 5Kunsch C, Medford RM. Oxidative stress as a regulator of gene expression in the vasculature. Circ Res, 1999,85:753-766.
  • 6Erbagei A, Tarakcioglu M, Coskum Y, et al. Mediators of inflammation in children with type 1 diabetes mellitus: cytokines in type 1 diabetic children. Clin Biochem, 2001,34:645-650.
  • 7Pickup JC, Mattock MB, Chusney GD, et al. NIDDM as disease of the innate immune system: association of acute reactants and interleukin-6 with metabolic syndrome X. Diabetologia, 1997,40:1286-1292.

共引文献169

同被引文献28

  • 1Serafinceanu C, Neculaescu C, Cimponeriu D, et al. Impact of gender and dialysis modality on early mortality risk in diabetic ESRD patients: data from a large single center cohort[J]. Int Urol Nephrol, 2014, 46(3): 607-614. DOh 10.1007/sl 1255-013- 0589-6.
  • 2Okayama KI, Mita T, Gosho M, et al. Carotid intima- media thickness progression predicts cardiovascular events in Japanese patients with type 2 diabetes[J]. Diabetes Res Clin Pract, 2013, 101(3): 286- 292. DOh 10.1016/j.diabres.2013. 06.008.
  • 3Levey AS, Stevens LA. Estimating GFR using the CKD Epidemiology Collaboration (CKD- EPI) ereatinine equation: accurate GFR estimates, lower CKD prevalence estimates, and better risk predietions[J]. Am J Kidney Dis, 2010, 55(4): 622-627. DOI: 10.1053/j.ajkd.2010.02.337.
  • 4Watanabe K, Oba K, Suzuki T, et al. Oral glucose loading attenuates endothelial function in normal individual[J]. Eur J Clin Invest, 2011, 41(5): 465-473. DOI: 10.1111/j.1365-2362. 2010.02424.x.
  • 5Holman RR, Paul SK, Bethel MA, et al. 10-year follow-up of intensive glucose control in type 2 diabetes[J]. N Engl J Med, 2008, 359(15): 1577-1589. DOI: 10.1056/NEJMoa 0806470.
  • 6Kampus P, Kals J, Ristimae T, et al. Augmentation index and carotid intima-media thickness are differently related to age, C- reactive protein and oxidized low- density lipoprotein[J]. J Hypertens, 2007, 25(4): 819-825. DOI: 10.1097/HJH.0b013 e328014952b.
  • 7Torres FS, Fuchs SC, Maestri MK, et al. Association between carotid intima- media thickness and retinal arteriolar and venular diameter in patients with hypertension: a cross- sectional study[J]. Atherosclerosis, 2013, 229(1): 134-138. DOI: 10.1016/j.atherosclerosis.2013.04.019.
  • 8Lopes- Virella MF, Hunt K J, Baker NL, et al. Levels of oxidized LDL and advanced glycation end products- modified LDL in circulating immune complexes are strongly associated with increased levels of carotid intima-media thickness and itsprogression in type 1 diabetes[J]. Diabetes, 2011, 60(2): 582- 589. DOI: 10.2337/db10-0915.
  • 9Tanaka M, Abe Y, Furukado S, et al. Chronic kidney disease and carotid atheroselerosis [J]. J Stroke Cerebrovase Dis, 2012, 21(1): 47-51. DOI: 10.1016/j.jstrokeeerebrovasdis.2010.03.018.
  • 10Boyle EM Jr, Lille ST, Allaire E, et al. Endothelial cell injury in cardiovascular surgery: atherosclerosis[J]. Ann Thorac Surg, 1997, 63(3): 885-894.

引证文献2

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部